Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections

Infection and Immunity

Volumn 74, Issue 9, 2006, Pages 5402-5407

  Lawlor, Matthew S ^a   Handley, Scott A ^a   Miller, Virginia L ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8230 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; CYTOKINE; PROTEIN CPSB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROBACTER INFECTION; IMMUNE RESPONSE; IMMUNIZATION; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL PROTEINS; CYTOKINES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MICE, INBRED C57BL; PNEUMONIA, BACTERIAL;

EID: 33748066974     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00244-06     Document Type: Article

References (32)

1. Baer, H., and L. Ehrenworth. 1956. The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide. J. Bacteriol. 72:713-717.
2. Camprubi, S., S. Merino, V. J. Benedi, and J. M. Tomas. 1993. The role of the O-antigen lipopolysaccharide and capsule on an experimental Klebsiella pneumoniae infection of the rat urinary tract. FEMS Microbiol. Lett. 111: 9-13.
3. Chang, H.-Y., J. H. Lee, W. L. Deng, T. F. Fu, and H. L. Peng. 1996. Virulence and outer membrane properties of a galU mutant of Klebsiella pneumoniae CG43. Microb. Pathog. 20:255-261.
4. Chhibber, S., S. Aggarwal, and V. Yadav. 2003. Contribution of capsular and lipopolysaccharide antigens to the pathogenesis of Klebsiella pneumoniae respiratory tract infection. Folia Microbiol. 48:699-702.
5. Chhibber, S., S. Wadhwa, and V. Yadav. 2004. Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia. Jpn. J. Infect. Dis. 57:150-155.
6. Cortes, G., N. Borrell, B. de Astorza, C. Gomez, J. Sauleda, and S. Alberti. 2002. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect. Immun. 70:2583-2590.
7. Cryz, S. J., Jr., E. Furer, and R. Germanier. 1986. Immunization against fatal experimental Klebsiella pneumoniae pneumonia. Infect. Immun. 54:403-407.
8. Cryz, S. J., Jr., E. Furer, and R. Germanier. 1984. Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide. J. Infect. Dis. 150: 817-822.
9. Dallaire, F., N. Ouellet, Y. Bergeron, V. Turmel, M. C. Gauthier, M. Simard, and M. G. Bergeron. 2001. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J. Infect. Dis. 184:292-300.
10. Domenico, P., W. G. Johanson, Jr., and D. C. Straus. 1982. Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect. Immun. 37:327-335.
11. Favre-Bonte, S., T. R. Licht, C. Forestier, and K. A. Krogfelt. 1999. Klebsiella pneumoniae capsule expression is necessary for colonization of large intestines of streptomycin-treated mice. Infect. Immun. 67:6152-6156.
12. Greenberger, M. J., S. L. Kunkel, R. M. Strieter, N. W. Lukacs, J. Bramson, J. Gauldie, F. L. Graham, M. Hitt, J. M. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 157:3006-3012.
13. Handley, S. A., P. H. Dube, and V. L. Miller. 2006. Histamine signaling through the H2 receptor in the Peyer's patch is important for controlling Yersinia enterocolitica infection. Proc. Natl. Acad. Sci. USA 103:9268-9273.
14. Handley, S. A., P. H. Dube, P. A. Revell, and V. L. Miller. 2004. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Infect. Immun. 72:1645-1656.
15. Inzana, T., J. Todd, and H. Veit. 1993. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect. Immun. 61:1682-1686.
16. Laichalk, L. L., S. L. Kunkel, R. M. Strieter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211-5218.
17. Lavender, H. F., J. R. Jagnow, and S. Clegg. 2004. Biofilm formation in vitro and virulence in vivo of mutants of Klebsiella pneumoniae. Infect. Immun. 72:4888-4890.
18. Lawlor, M. S., J. Hsu, P. D. Rick, and V. L. Miller. 2005. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol. Microbiol. 58:1054-1073.
19. Lindell, D. M., T. J. Standiford, P. Mancuso, Z. Leshen, and G. B. Huffnagle. 2001. Macrophage inflammatory protein 1a/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect. Immun. 69: 6364-6369.
20. Moore, T. A., M. L. Perry, A. G. Getsoian, M. W. Newstead, and T. J. Standiford. 2002. Divergent role of gamma interferon in a murine model of pulmonary versus systemic Klebsiella pneumoniae infection. Infect. Immun. 70:6310-6318.
21. Scott, H. M., and J. L. Flynn. 2002. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70:5946-5954.
22. Simoons-Smit, A. M., A. M. Verweij-van Vught, and D. M. MacLaren. 1986. The role of K antigens as virulence factors in Klebsiella. J. Med. Microbiol. 21:133-137.
23. Standiford, T. J., J. M. Wilkowski, T. H. Sisson, N. Hattori, B. Mehrad, K. A. Bucknell, and T. A. Moore. 1999. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia. Hum. Gene Ther. 10:899-909.
24. Struve, C., and K. A. Krogfelt. 2003. Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS Microbiol. Lett. 218:149-154.
25. Takahashi, M., K. Yoshida, and C. L. San Clemente. 1977. Relation of colonial morphologies in soft agar to morphologies and biological properties of the K-9 strain of Klebsiella pneumoniae and is variants. Can. J. Microbiol. 23:448-451.
26. Tanabe, M., T. Matsumoto, K. Shibuya, K. Tateda, S. Miyazaki, A. Nakane, Y. Iwakura, and K. Yamaguchi. 2005. Compensatory response of IL-1 gene knockout mice after pulmonary infection with Klebsiella pneumoniae. J. Med. Microbiol. 54:7-13.
27. Tomas, J. M., S. Camprubi, S. Merino, M. R. Davey, and P. Williams. 1991. Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens. Infect. Immun. 59:2006-2011.
28. Yadav, V., S. Sharma, K. Harjai, H. Mohan, and S. Chibber. 2005. Lipopolysaccharide-mediated protection against Klebsiella pneumoniae-induced lobar pneumonia: intranasal versus intramuscular route of immunization. Folia Microbiol. 50:83-86.
29. Ye, P., P. B. Garvey, P. Zhang, S. Nelson, G. Bagby, W. R. Summer, P. Schwarzenberger, J. E. Shellito, and J. K. Kolls. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell. Mol. Biol. 25:335-340.
30. Yoshida, K., T. Matsumoto, K. Tateda, K. Uchida, S. Tsujimoto, Y. Iwakura, and K. Yamaguchi. 2001. Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-γ through activation of phagocytic cells and stimulation of production of other cytokines. J. Med. Microbiol. 50:959-964.
31. Yoshida, K., T. Matsumoto, K. Tateda, K. Uchida, S. Tsujimoto, and K. Yamaguchi. 2001. Induction of interleukin-10 and down-regulation of cytokine production by Klebsiella pneumoniae capsule in mice with pulmonary infection. J. Med. Microbiol. 50:456-461.
32. Yoshida, K., T. Matsumoto, K. Tateda, K. Uchida, S. Tsujimoto, and K. Yamaguchi. 2000. Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae. J. Med. Microbiol. 49:1003-1010.